Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

Press releases published on November 3, 2026

Nov. 3, 2026

Viirtue Moves Into New Downtown St. Petersburg Office at 360 Central Avenue

Indeterminate EIN Presswire

Nov. 3, 2026

MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer

Indeterminate GlobeNewswire

Nov. 3, 2026

Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities

Indeterminate GlobeNewswire

Nov. 3, 2026

Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion

Indeterminate GlobeNewswire

Nov. 3, 2026

Cardiff Oncology to Participate in the UBS Global Biopharma Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Maze Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

ZENOTTIC Unveils New Global Brand Direction With “A Pair for Every You”

Indeterminate GlobeNewswire

Nov. 3, 2026

Seyond Expands Smart City Solution with LiDAR-Powered Operational Twin Capabilities and Technology Collaborations

Indeterminate GlobeNewswire

Nov. 3, 2026

Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Madrigal Pharmaceuticals Reports Third-Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Nov. 3, 2026

Parabilis Medicines to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Opus Genetics to Present at the Guggenheim Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

OutSolve Named a 2026 Inc. Power Partner for Business Products and Services

Indeterminate GlobeNewswire

Nov. 3, 2026

Cartesian Therapeutics Announces New Employment Inducement Grant

Indeterminate GlobeNewswire

Nov. 3, 2026

Tango Therapeutics to Participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Hemab Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 10, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Jade Biosciences to Participate in Upcoming Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Nov. 3, 2026

C4 Therapeutics to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire